₹505.85▲1.2%
2.12%
Low
Day's Volatility:3.52%
High
1.40%
29.73%
Low
52 Weeks Volatility:96.78%
High
67.05%
Returns % | |
1 Month Return | 17.95 % |
3 Month Return | 4.18 % |
1 Year Return | -26.58 % |
Market Stats | |
Previous Close | ₹499.85 |
Open | ₹499.00 |
Volume | 8,572.00 |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹632.37Cr |
Organisation | Medicamen Biotech Ltd |
Headquarters | |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Medicamen Biotech Ltd
Shares of Medicamen Biotech jumped 20% to hit the upper circuit after the United States Food and Drug Administration inspected its oncology formulation facility in Haridwar. The inspection closed with six procedural observations, which were complied with proactively and acknowledged by the auditor. However, the final approval (EIR) is expected after submission of formal response to FDA.
Insiders of Medicamen Biotech Sell Shares - 27 Apr, 2024
Insiders of Medicamen Biotech have sold ₹20m worth of stock over the last year at an average price of ₹170, which is higher than the current price. Geetika Madan made the biggest insider sale in the last 12 months, selling ₹11m worth of shares at a price of ₹384 each.
Fundamentals of Medicamen Biotech Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
Revenue is up for the last 8 quarters, 23.09 Cr → 47.33 Cr (in ₹), with an average increase of 9.1% per quarter
Price Rise
In the last 1 month, MEDICAMEQ stock has moved up by 18.0%
Profit Spike
Netprofit is up for the last 2 quarters, 1.51 Cr → 2.03 Cr (in ₹), with an average increase of 25.6% per quarter
Against Peers
In the last 1 year, Sun Pharmaceuticals Industries Ltd has given 56.8% return, outperforming this stock by 83.3%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 43.21% of holdings in Mar 2024 quarter
Retail Holding Down
Retail Investor have decreased holdings from 55.90% to 55.69% in Mar 2024 quarter
FII Holding Down
Foreign Institutions have decreased holdings from 0.21% to 0.11% in Mar 2024 quarter
Medicamen Biotech Ltd in the last 5 years
Lowest (41.41x)
March 13, 2024
Today (56.71x)
May 10, 2024
Industry (60.42x)
May 10, 2024
Highest (102.33x)
September 1, 2022
Investors | Holdings % | Prev. 1 periods | 3M change |
---|---|---|---|
Promoter Holdings | 43.21% | 0.00 | |
Foreign Institutions | 0.11% | 0.00 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 55.69% | 0.00 | |
Others | 0.99% | 0.00 |
Technicals of Medicamen Biotech Ltd share
News & Events of Medicamen Biotech Ltd
Medicamen Biotech Ltd (MEDICAMEQ) share price today is ₹505.85
Medicamen Biotech Ltd is listed on NSE
Medicamen Biotech Ltd is listed on BSE
PE Ratio of Medicamen Biotech Ltd is 56.71
PE ratio = Medicamen Biotech Ltd Market price per share / Medicamen Biotech Ltd Earnings per share
Today’s traded volume of Medicamen Biotech Ltd(MEDICAMEQ) is 8,572.00.
Today’s market capitalisation of Medicamen Biotech Ltd(MEDICAMEQ) is ₹632.37Cr.
Medicamen Biotech Ltd(MEDICAMEQ | Price |
---|---|
52 Week High | ₹845 |
52 Week Low | ₹355.45 |
Medicamen Biotech Ltd(MEDICAMEQ) share price is ₹505.85. It is down -40.14% from its 52 Week High price of ₹845
Medicamen Biotech Ltd(MEDICAMEQ) share price is ₹505.85. It is up 42.31% from its 52 Week Low price of ₹355.45
Medicamen Biotech Ltd(MEDICAMEQ | Returns |
---|---|
1 Day Returns | 6% |
1 Month Returns | 17.95% |
3 Month Returns | 4.18% |
1 Year Returns | -26.58% |